Herpes zoster in patients with glioma treated with temozolomide
- 1 September 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 129, 110816
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesPediatric Blood & Cancer, 2023
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- Hepatitis B virus reactivation during temozolomide administration for malignant gliomaInternational Journal of Clinical Oncology, 2021
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell TransplantationJAMA, 2019
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyThe Lancet Oncology, 2016
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older AdultsNew England Journal of Medicine, 2015
- Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomasCritical Reviews in Oncology/Hematology, 2013
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic GliomasJournal of Neuro-Oncology, 2004
- Index for rating diagnostic testsCancer, 1950